Search:Healthcare Network
-
Healthcare Network 29th meeting
- Nagoya
- Number of participants 15
Subject
- How medical marketing should work in the post-corona era.
- About the future of pharmaceutical wholesalers.
-
Healthcare Network 31st meeting
- Osaka
- Number of participants 17
Subject
- Will Japan need industrial physicians in the future?
- Thinking about the form of "regional medical cooperation" that has emerged from the experience of the coronavirus pandemic - A case study from the Chubu Medical Area of Okinawa Prefecture -
-
Healthcare Network 33rd meeting
- Tokyo
- Number of participants 51
Subject
- The gap between the correctness of corporate reform and the values of employees.
- Collaboration between venture companies and large companies and employee careers in the healthcare industry.
- How can pharmaceutical companies balance social contribution with their own profits?
-
Healthcare Network 28th meeting
- Nagoya
- Number of participants 21
Subject
- What is the essence of hospital management?
- For the pharmaceutical industry, a high-risk industry where the difficulty of creating new drugs is increasing, can "fundamental treatment" and "health care services" bring about a new paradigm shift?
- What should the government's next steps be to realize Japan's data health society?
-
Healthcare Network 30th meeting
- Osaka
- Number of participants 23
Subject
- How should we consider our next move in the closed market of pharmaceutical wholesale?
- Global expansion of drug discovery ventures - Possibilities of CJK platform business -
-
Healthcare Network 32nd meeting
- Tokyo
- Number of participants 31
Subject
- Why was Pfizer able to develop the COVID 19 vaccine faster than anyone else?
- Health risks of medical sterilization gases to the general public and business models for risk reduction
- What is the key to the success of a new business division at a pharmaceutical company?
-
Healthcare Network 29th meeting
- Osaka
- Number of participants 21
Subject
- What value can universities provide to pharmaceutical companies and society?
- How venture companies should be organized in the pharmaceutical and medical device industries in the 2020s (post-Corona)?
- What is the optimal solution for PSI control for food manufacturers?
-
Healthcare Network 31st meeting
- Tokyo
- Number of participants 48
Subject
- Is the Company's Interest Prioritized? Patient Profit?
- Actual demand for ambulances at emergency rooms in urban and suburban areas
- Future sales methods and systems of pharmaceutical companies
-
Healthcare Network 27th meeting
- Nagoya
- Number of participants 16
Subject
- How to Reject Past Decisions and Transform Your Business
- Will the day really come when Japan can combine coronary infection prevention and economic activity?
-
Healthcare Network 30th meeting
- Tokyo
- Number of participants 28
Subject
- New Work Styles for Medical Office Staff Supporting Busy Home Healthcare
- Will the day really come when Japan can combine coronary infection prevention and economic activity?
-
Healthcare Network 28th meeting
- Osaka
- Number of participants 11
Subject
- The Development of Remote MRs for Pharmaceutical Companies
- Will the day really come when coronary infection prevention and economic activity are compatible in Japan?
-
Healthcare Network 26th meeting
- Nagoya
- Number of participants 12
Subject
- Preventive Medicine in Japan - Are Japanese People Healthy?
- The Future of Home Healthcare as a Healthcare Industry in Japan